Parnassia Groep B.V.

2 trials 2 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

3 Countries active

5 Unique IMPs

N/A Results reported

Phase III

Phase IV

Phase III: 1 Phase IV: 1

Top indications

Anxiety disorder 1 Psychotic disorder 1

Top IMPs

DEXAMFETAMINE SULFATE, PIRACETAM 1

All trials

2 total

REDUCE: Research on sustained-release dexamphetamine treatment for cocaine use disorder Recruiting

2023-505556-21-00 Phase III 1 country DEXAMFETAMINE SULFATE, PIRACETAM
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Phase IV 3 countries

Showing 1–2 of 2 trials

← All sponsors A–Z